Get your tech, your data, and your people ready
While Novartis started with Celonis’ on-premise solution, it later switched to the cloud. This system migration, while daunting, was supported by its initial work with Celonis, the expertise it had already built, and a cautious, data-driven approach. According to Mishra, pharma companies are wary of digital change due to tight regulations. With this in mind, the Novartis team only made decisions when they had a clear idea of what the technical, privacy, and regulatory consequences would be – weighing effort and risk against potential advantages. In the case of Celonis on-premise vs. Celonis in the cloud, the cloud’s new capabilities (like Action Flows) and ease of use won out. Celonis in the cloud, Mishra said, ultimately represented better value.
To make effective use of Celonis, Novartis carefully selects what data Celonis will ingest to ensure output — like dashboards and analyses — is high-quality. “Garbage in generates garbage out,” Mishra neatly summed up. The company also incorporates regular governance of data, both for compliance and quality assurance, and because doing so builds trust with business and process owners.
Guiding all this are Novartis’ process experts, whose appointment and training is itself a careful process. It looks and trains for comfort with process tools that goes beyond the basic level, hoping that talents will evolve over time alongside the tools they’re using. One of the best predictors for success is often the ability of process workers in business units to successfully work together with IT teams.